Your browser doesn't support javascript.
loading
Pazopanib or methotrexate-vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 study.
Toulmonde, Maud; Pulido, Marina; Ray-Coquard, Isabelle; Andre, Thierry; Isambert, Nicolas; Chevreau, Christine; Penel, Nicolas; Bompas, Emmanuelle; Saada, Esma; Bertucci, François; Lebbe, Celeste; Le Cesne, Axel; Soulie, Patrick; Piperno-Neumann, Sophie; Sweet, Stephen; Cecchi, Fabiola; Hembrough, Todd; Bellera, Carine; Kind, Michèle; Crombe, Amandine; Lucchesi, Carlo; Le Loarer, François; Blay, Jean-Yves; Italiano, Antoine.
  • Toulmonde M; Department of Medicine, Institut Bergonié, Bordeaux, France.
  • Pulido M; Clinical and Epidemiology Department and Clinical Investigation Centre, INSERM, Institut Bergonié, Bordeaux, France.
  • Ray-Coquard I; Department of Medicine, Centre Léon Bérard, Lyon, France.
  • Andre T; Department of Medical Oncology, Hôpital Saint-Antoine, Paris, France.
  • Isambert N; Department of Medicine, Centre George-Francois Leclerc, Dijon, France.
  • Chevreau C; Department of Medicine, Oncopole, Toulouse, France.
  • Penel N; Department of Medicine, Centre Oscar Lambret, Lille, France.
  • Bompas E; Department of Medicine, Institut de Cancérologie de l'Ouest, Nantes, France.
  • Saada E; Department of Medicine, Centre Antoine Lacassagne, Nice, France.
  • Bertucci F; Department of Medicine, Institut Paoli Calmettes, Marseille, France.
  • Lebbe C; Department of Dermatology, Hôpital Saint-Louis, France.
  • Le Cesne A; Department of Medicine, Gustave Roussy, Villejuif, France.
  • Soulie P; Department of Medicine, Institut de Cancérologie de l'Ouest, Angers, France.
  • Piperno-Neumann S; Department of Medicine, Institut Curie, Paris, France.
  • Sweet S; NantOmics, Rockville, MD, USA.
  • Cecchi F; NantOmics, Rockville, MD, USA.
  • Hembrough T; NantOmics, Rockville, MD, USA.
  • Bellera C; Clinical and Epidemiology Department and Clinical Investigation Centre, INSERM, Institut Bergonié, Bordeaux, France.
  • Kind M; Department of Radiology, Institut Bergonié, Bordeaux, France.
  • Crombe A; Department of Radiology, Institut Bergonié, Bordeaux, France.
  • Lucchesi C; Bioinformatics Unit, Institut Bergonié, Bordeaux, France.
  • Le Loarer F; Department of Pathology, Institut Bergonié, Bordeaux, France.
  • Blay JY; Department of Medicine, Centre Léon Bérard, Lyon, France.
  • Italiano A; Department of Medicine, Institut Bergonié, Bordeaux, France; University of Bordeaux, Bordeaux, France. Electronic address: a.italiano@bordeaux.unicancer.fr.
Lancet Oncol ; 20(9): 1263-1272, 2019 09.
Article en En | MEDLINE | ID: mdl-31331699
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirimidinas / Sulfonamidas / Vinblastina / Metotrexato / Fibromatosis Agresiva Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirimidinas / Sulfonamidas / Vinblastina / Metotrexato / Fibromatosis Agresiva Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article